Research and experimental development on natural sciences and engineering
ECCELODIUS AS
Revenue 2025
NOK 0
Operating profit
NOK −64,000
Equity
NOK −46,000
Incorporated
2021
Share capital
NOK 30,000
Roles
Daglig lederÅke Elden
Regnskapsfører
Styrets lederÅke Elden
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| ÅKE ELDEN | 100.0% | 3000.000000 | 2025 |
Holdings in other companies
| Company | Status | Stake | Shares |
|---|---|---|---|
| ECCELUDE AS | Active | 100.0% | 3000.000000 |
| CROESUS INVEST AS | Active | 50.0% | 15000.000000 |
| HUMENO AS | unknown | 50.0% | 15000.000000 |
| GRAPHOGAME SPV AS | Active | 0.0% | 20.000000 |
| BOOKIS SPV AS | Active | 0.0% | 20.000000 |
| IMMUVERA THERAPEUTICS AS | Active | 0.0% | 1692.000000 |
| SULTEN AS | Active | 0.0% | 3335.000000 |
| PHARMASUM THERAPEUTICS AS | Active | 0.0% | 500.000000 |
| BRAVO MARINE AS | Active | 0.0% | 45.000000 |
| SHIP O HOI AS | Active | 0.0% | 20.000000 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.